Environmental factors and cardiovascular diseases

Cover Page

Cite item

Full Text

Abstract

Introduction. New advances in the diagnosis and treatment of cardiovascular diseases (CVD), as practice shows, are not able to significantly improve the statistical indicators of morbidity and mortality of CVD. This fact indicates that there are additional factors and mechanisms that are important to consider, both for prevention and for the most optimal management of patients. Recently, the relationship between environmental and lifestyle factors with CVD has been actively studied. However, despite understanding the relationship between environmental factors and various diseases, including CVD, the mechanisms by which specific factors increase or decrease the risk of developing CVD are not yet fully understood, and a number of studies are contradictory.

The aim of our work was to generalize existing data on the impact of such critical environmental factors as air pollution and solar insolation on the cardiovascular system, as well as to comprehensively discuss the mechanisms by which these environmental factors can participate in the development and progression of CVD. To achieve our work’s goal, we analyzed modern foreign literature using the PubMed database.

Conclusion. According to numerous experimental and clinical studies, air pollution and solar insolation deficiency play an essential role in developing CVD and the aggravation of patients with various CVD (atherosclerosis, hypertension, coronary heart disease, heart failure, myocardial infarction, and stroke). Thus, air pollution and lack of solar insolation can be considered as critical risk factors for CVD. Future research should focus on the study and establishment of specific pathogenetic mechanisms by which environmental factors affect the cardiovascular system’s health to develop effective treatment and prevention measures.

About the authors

Aleksey M. Chaulin

Samara State Medical University; Samara regional clinical cardiology dispensary

Author for correspondence.
Email: alekseymichailovich22976@gmail.com
ORCID iD: 0000-0002-2712-0227

MD, post-graduate student, assistant of the department of the Samara State Medical University, Samara, 443079, Russian Federation; doctor Samara regional clinical cardiology dispensary, Samara, 443070, Russian Federation.

e-mail: alekseymichailovich22976@gmail.com

Russian Federation

Dmitry V. Duplyakov

Samara State Medical University; Samara regional clinical cardiology dispensary

Email: noemail@neicon.ru
ORCID iD: 0000-0002-6453-2976
Russian Federation

References

  1. Yakushin S.S., Filippov E.V. Prevention of cardiovascular diseases is a healthy lifestyle strategy. Vrach. 2011; (9): 2–7. (in Russian)
  2. Chaulin A.M., Karslyan L.S., Grigor’eva E.V., Nurbaltaeva D.A., Duplyakov D.V. Clinical and diagnostic value of cardiac markers in human biological fluids. Kardiologiya. 2019; 59(11): 66–75. https://doi.org/10.18087/cardio.2019.11.n414 (in Russian)
  3. Bazdyrev E.D., Barbarash O.L. Ecology and cardiovascular diseases. Ekologiya cheloveka. 2014; (5): 53–9. (in Russian)
  4. Arkhipovskiy V.L. Cardiovascular pathology: prevalence, main risk factors. Ekologiya cheloveka. 2007; (7): 20–5. (in Russian)
  5. Almetwally A.A., Bin-Jumah M., Allam A.A. Ambient air pollution and its influence on human health and welfare: an overview. Environ. Sci. Pollut. Res. Int. 2020; 27(20): 24815–30. https://doi.org/10.1007/s11356-020-09042-2
  6. Hartung T. Toxicology for the twenty-first century. Nature. 2009; 460(7252): 208–12. https://doi.org/10.1038/460208a
  7. Wilkening K.E., Barrie L.A., Engle M. Atmospheric science. trans-Pacific air pollution. Science. 2000; 290(5489): 65–7. https://doi.org/10.1126/science.290.5489.65
  8. Lelieveld J., Evans J.S., Fnais M., Giannadaki D., Pozzer A. The contribution of outdoor air pollution sources to premature mortality on a global scale. Nature. 2015; 525(7569): 367–71. https://doi.org/10.1038/nature15371
  9. Caiazzo F., Ashok A., Waitz I.A., Yim S.H., Barrett S.R. Air pollution and early deaths in the United States. Part I: Quantifying the impact of major sectors in 2005. Atmos. Environ. 2013; 79: 198–208. https://doi.org/10.1016/j.atmosenv.2013.05.081
  10. Cosselman K.E., Navas-Acien A., Kaufman J.D. Environmental factors in cardiovascular disease. Nat. Rev. Cardiol. 2015; 12(11): 627–42. https://doi.org/10.1038/nrcardio.2015.152
  11. Bhatnagar A. Environmental cardiology: studying mechanistic links between pollution and heart disease. Circ. Res. 2006; 99(7): 692–705. https://doi.org/10.1161/01.RES.0000243586.99701.cf
  12. Gold D.R., Mittleman M.A. New insights into pollution and the cardiovascular system: 2010 to 2012. Circulation. 2013; 127(18): 1903–13. https://doi.org/10.1161/CIRCULATIONAHA.111.064337
  13. Puett R.C., Hart J.E., Suh H., Mittleman M., Laden F. Particulate matter exposures, mortality, and cardiovascular disease in the health professionals follow-up stud. Environ. Health Perspect. 2011; 119(8): 1130–5. https://doi.org/10.1289/ehp.1002921
  14. Pope C.A. 3rd., Bhatnagar A., McCracken J.P., Abplanalp W., Conklin D.J., O’Toole T. Exposure to fine particulate air pollution is associated with endothelial injury and systemic inflammation. Circ. Res. 2016; 119(11): 1204–14. https://doi.org/10.1161/CIRCRESAHA.116.309279
  15. Bauer M., Moebus S., Mohlenkamp S., Dragano N., Nonnemacher M., Fuchsluger M., et al. Urban particulate matter air pollution is associated with subclinical atherosclerosis: results from the HNR (Heinz Nixdorf Recall) study. J. Am. Coll. Cardiol. 2010; 56(22): 1803–8. https://doi.org/10.1016/j.jacc.2010.04.065
  16. Hoffmann B., Moebus S., Dragano N., Stang A., Mohlenkamp S., Schmermund A., et al. Chronic residential exposure to particulate matter air pollution and systemic inflammatory markers. Environ. Health Perspect. 2009; 117(8): 1302–8. https://doi.org/10.1289/ehp.0800362
  17. Kingsley S.L., Eliot M.N., Whitsel E.A., Wang Y., Coull B.A., Hou L., et al. Residential proximity to major roadways and incident hypertension in post-menopausal women. Environ. Res. 2015; 142: 522–8. https://doi.org/10.1016/j.envres.2015.08.002
  18. Tonne C., Melly S., Mittleman M., Coull B., Goldberg R., Schwartz J. A case-control analysis of exposure to traffic and acute myocardial infarction. Environ. Health Perspect. 2007; 115(1): 53–7. https://doi.org/10.1289/ehp.9587
  19. Wilker E.H., Mostofsky E., Lue S.H., Gold D., Schwartz J., Wellenius G.A., et al. Residential proximity to high-traffic roadways and poststroke mortality. J. Stroke Cerebrovasc. Dis. 2013; 22(8): e366–72. https://doi.org/10.1016/j.jstrokecerebrovasdis.2013.03.034
  20. Bhatnagar A. Cardiovascular pathophysiology of environmental pollutants. Am. J. Physiol. Heart Circ. Physiol. 2004; 286: H479–85. https://doi.org/10.1152/ajpheart.00817.2003
  21. Conklin D.J., Barski O.A., Lesgards J.F., Juvan P., Rezen T., Rozman D., et al. Acrolein consumption induces systemic dyslipidemia and lipoprotein modification. Toxicol. Appl. Pharmacol. 2010; 243(1): 1–12. https://doi.org/10.1016/j.taap.2009.12.010
  22. Conklin D.J., Haberzettl P., Prough R.A., Bhatnagar A. Glutathione-S-transferase P protects against endothelial dysfunction induced by exposure to tobacco smoke. Am. J. Physiol. Heart Circ. Physiol. 2009; 296(5): H1586–97. https://doi.org/10.1152/ajpheart.00867.2008
  23. Chaulin A.M., Grigor’eva Yu.V., Duplyakov D.V. Comboridity of chronic obstructive pulmonary disease and cardiovascular diseases: general factors, pathophysiological mechanisms and clinical significance. Klinicheskaya praktika. 2020; 11(1): 112–21. https://doi.org/10.17816/clinpract21218 (in Russian)
  24. Rao X., Zhong J., Maiseyeu A., Gopalakrishnan B., Villamena F.A., Chen L.C., et al. CD36-dependent 7-ketocholesterol accumulation in macrophages mediates progression of atherosclerosis in response to chronic air pollution exposure. Circ. Res. 2014; 115(9): 770–80. https://doi.org/10.1161/CIRCRESAHA.115.304666
  25. Haberzettl P., O‘Toole T.E., Bhatnagar A., Conklin D.J. Exposure to fine particulate air pollution causes vascular insulin resistance by inducing pulmonary oxidative stress. Environ. Health Perspect. 2016; 124(12): 1830–9. https://doi.org/10.1289/EHP212
  26. Yang L., Lof M., Veierod M.B., Sandin S., Adami H.O., Weiderpass E. Ultraviolet exposure and mortality among women in Sweden. Cancer Epidemiol. Biomarkers Prev. 2011; 20(4): 683–90. https://doi.org/10.1158/1055-9965.EPI-10-0982
  27. Lindqvist P.G., Epstein E., Nielsen K., Landin-Olsson M., Ingvar C., Olsson H. Avoidance of sun exposure as a risk factor for major causes of death: a competing risk analysis of the Melanoma in Southern Sweden cohort. J. Intern. Med. 2016; 280(4): 375–87. https://doi.org/10.1111/joim.12496
  28. Donneyong M.M., Taylor K.C., Kerber R.A., Hornung C.A., Scragg R. Is outdoor recreational activity an independent predictor of cardiovascular disease mortality – NHANES III? Nutr. Metab. Cardiovasc. Dis. 2016; 26(8): 735–42. https://doi.org/10.1016/j.numecd.2016.02.008
  29. Clemens T.L., Adams J.S., Henderson S.L., Holick M.F. Increased skin pigment reduces the capacity of skin to synthesise vitamin D3. Lancet. 1982; 1(8263): 74–6. https://doi.org/10.1016/s0140-6736(82)90214-8
  30. Alemzadeh R., Kichler J., Babar G., Calhoun M. Hypovitaminosis D in obese children and adolescents: relationship with adiposity, insulin sensitivity, ethnicity, and season. Metabolism. 2008; 57(2): 183–91. https://doi.org/10.1016/j.metabol.2007.08.023
  31. Cheng S., Massaro J.M., Fox C.S., Larson M.G., Keyes M.J., McCabe E.L., et al. Adiposity, cardiometabolic risk, and vitamin D status: the Framingham Heart Study. Diabetes. 2010; 59(1): 242–8. https://doi.org/10.2337/db09-1011
  32. Rostand S.G. Ultraviolet light may contribute to geographic and racial blood pressure differences. Hypertension. 1997; 30(2 Pt. 1): 150–6. https://doi.org/10.1161/01.hyp.30.2.150
  33. Argiles A., Mourad G., Mion C. Seasonal changes in blood pressure in patients with end-stage renal disease treated with hemodialysis. N. Engl. J. Med. 1998; 339(19): 1364–70. https://doi.org/10.1056/NEJM199811053391904
  34. Lee J.H., O’Keefe J.H., Bell D., Hensrud D.D., Holick M.F. Vitamin D deficiency an important, common, and easily treatable cardiovascular risk factor? J. Am. Coll. Cardiol. 2008; 52(24): 1949–56. https://doi.org/10.1016/j.jacc.2008.08.050
  35. Bouillon R., Carmeliet G., Verlinden L., van Etten E., Verstuyf A., Luderer H.F., et al. Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr. Rev. 2008; 29(6): 726–76. https://doi.org/10.1210/er.2008-0004
  36. Wang T.J. Vitamin D and Cardiovascular Disease. Annu Rev Med. 2016; 67: 261–272. https://doi.org/10.1146/annurev-med-051214-025146.
  37. Pilz S., Verheyen N., Grubler M.R., Tomaschitz A., Marz W. Vitamin D and cardiovascular disease prevention. Nat. Rev. Cardiol. 2016; 13(7): 404–17. https://doi.org/10.1038/nrcardio.2016.73
  38. Rylova N.V., Zholinskiy A.V. Role of vitamin D in prophylaxis of cardiovascular diseases. Prakticheskaya meditsina. 2020; 18(1): 50–3. https://doi.org/10.32000/2072-1757-2020-1-50-53 (in Russian)
  39. Kunutsor S.K., Apekey T.A., Steur M. Vitamin D and risk of future hypertension: meta-analysis of 283,537 participants. Eur. J. Epidemiol. 2013; 28(3): 205–21. https://doi.org/10.1007/s10654-013-9790-2
  40. Autier P., Gandini S. Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials. Arch. Intern. Med. 2007; 167(16): 1730–7. https://doi.org/10.1001/archinte.167.16.1730
  41. Bjelakovic G., Gluud L.L., Nikolova D., Whitfield K., Wetterslev J., Simonetti R.G., et al. Vitamin D supplementation for prevention of mortality in adults. Cochrane Database Syst. Rev. 2014; (1): CD007470. https://doi.org/10.1002/14651858.CD007470.pub3
  42. Witte K.K., Byrom R., Gierula J., Paton M.F., Jamil H.A., Lowry J.E., et al. Effects of vitamin D on cardiac function in patients with chronic HF: The VINDICATE Study. J. Am. Coll. Cardiol. 2016; 67(22): 2593–603. https://doi.org/10.1016/j.jacc.2016.03.508
  43. Oplander C., Volkmar C.M., Paunel-Gorgulu A., van Faassen E.E., Heiss C., Kelm M., et al. Whole body UVA irradiation lowers systemic blood pressure by release of nitric oxide from intracutaneous photolabile nitric oxide derivates. Circ. Res. 2009; 105(10): 1031–40. https://doi.org/10.1161/CIRCRESAHA.109.207019
  44. West M.B., Rokosh G., Obal D., Velayutham M., Xuan Y.T., Hill B.G., et al. Cardiac myocyte-specific expression of inducible nitric oxide synthase protects against ischemia/reperfusion injury by preventing mitochondrial permeability transition. Circulation. 2008; 118(19): 1970–8. https://doi.org/10.1161/CIRCULATIONAHA.108.791533
  45. Sansbury B.E., Cummins T.D., Tang Y., Hellmann J., Holden C.R., Harbeson M.A., et al. Overexpression of endothelial nitric oxide synthase prevents diet-induced obesity and regulates adipocyte phenotype. Circ. Res. 2012; 111(9): 1176–89. https://doi.org/10.1161/CIRCRESAHA.112.266395
  46. Geldenhuys S., Hart P.H., Endersby R., Jacoby P., Feelisch M., Weller R.B., et al. Ultraviolet radiation suppresses obesity and symptoms of metabolic syndrome independently of vitamin D in mice fed a high-fat diet. Diabetes. 2014; 63(11): 3759–69. https://doi.org/10.2337/db13-1675

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2024 Chaulin A.M., Duplyakov D.V.


СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 37884 от 02.10.2009.